How Much Weight Can You Lose in One Month on Ozempic?

Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Ozempic, reduces hunger by mimicking glucagon-like peptide-1 (GLP-1), a natural hormone that regulates appetite and blood sugar. First-month weight loss typically ranges from 2 to 5 pounds, depending on individual factors like baseline weight and lifestyle changes. Understanding realistic expectations helps you stay motivated and work with your healthcare provider to optimize your treatment.

What Is Realistic One-Month Weight Loss on Semaglutide?

Clinical trials show that people starting semaglutide lose an average of 2–5 pounds during the first month, with some variation based on starting weight and metabolism. Those beginning at higher weights often see slightly larger initial drops because their bodies burn more calories at rest. The first month establishes a baseline—most significant weight loss accelerates in months 2–6 as doses increase and the medication's appetite-suppressing effects deepen.

Early-month results also depend on whether you're making concurrent dietary changes. Semaglutide doesn't magically melt fat; it reduces cravings and portion sizes, making it easier to eat fewer calories. Individuals who combine the medication with balanced nutrition and movement typically see faster and more sustainable progress than those who rely on semaglutide alone.

How Semaglutide Reduces Appetite and Food Intake

Semaglutide works by activating GLP-1 receptors in the brain's hunger centers, signaling fullness earlier and extending that sensation between meals. This mechanism doesn't suppress your appetite through stimulation like older weight-loss drugs; instead, it normalizes hunger signals that may have been dysregulated due to insulin resistance or obesity-related metabolic changes. Within days of starting, many patients report feeling satisfied with smaller portions and experiencing fewer cravings for high-sugar or high-fat foods.

The medication also slows stomach emptying, meaning food stays in your digestive system longer, prolonging satiety. Blood sugar stabilization is an additional benefit—by controlling glucose spikes and crashes, semaglutide reduces the energy dips that typically trigger overeating. These combined effects make adhering to a calorie deficit significantly easier without requiring extreme willpower.

Factors Affecting Your First-Month Weight Loss Results

Starting weight is one of the strongest predictors of first-month loss. A person weighing 300 pounds may lose 4–5 pounds, while someone at 180 pounds might lose 2–3 pounds—both represent similar percentages of total body weight. Age, baseline metabolism, thyroid function, and whether you have insulin resistance all influence how quickly your body responds. Additionally, medications you take for other conditions (antidepressants, diabetes drugs, steroids) can either support or slow weight loss.

Lifestyle adherence matters tremendously in month one. Those who eliminate sugary drinks, reduce processed foods, and add daily movement see faster results than those who make minimal changes. Sleep quality and stress management also play understated but critical roles—poor sleep increases cortisol, which can retain water and slow fat loss, while chronic stress may blunt the appetite-suppressing effect of semaglutide.

PlexusDx Semaglutide: Personalized Dosing and Affordability

PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies, starting at $149 per month regardless of your dose level. The pricing structure—flat monthly cost with no per-dose increases—means your dose may need to go up as you progress, but your price won't. This transparency removes a common barrier to treatment for people concerned about escalating medical costs.

PlexusDx also provides the optional Precision Peptide Genetic Test ($99 add-on after your first month) to identify genetic variants in the GLP1R, GIPR, FTO, and MC4R pathways. This test maps 14 metabolic pathways and 49 peptides, helping your provider understand whether you're a responder to GLP-1 monotherapy or might benefit from dual-compound protocols like GLP-Squared Injection. No insurance is required, and semaglutide is HSA/FSA eligible, making personalized weight loss accessible across all 50 states.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is losing 2–5 pounds in one month on semaglutide considered good progress?

Yes. Losing 1–2 pounds per week is considered safe, sustainable weight loss by medical standards. Month-one results are often modest because dosing typically starts low (0.25 mg) to assess tolerance; more significant losses usually occur in months 2–6 as your dose increases and your body adapts to the medication.

Why do some people lose more weight than others in their first month?

Starting weight, metabolic rate, age, genetic factors, and lifestyle changes all influence first-month results. Someone with obesity or insulin resistance may see faster initial drops, while genetic variants in the GLP1R and GIPR genes (tested via PlexusDx's Precision Peptide Genetic Test) can predict individual responsiveness to semaglutide.

How much does semaglutide cost at PlexusDx, and is it affordable?

PlexusDx compounded semaglutide injections start at $149 per month, with a flat rate regardless of your dose level—your price won't go up as you increase doses. The medication is HSA/FSA eligible and available nationwide without insurance, making it one of the most accessible options for personalized GLP-1 therapy.

Are there side effects that might slow weight loss in month one?

Common early side effects—nausea, constipation, reduced appetite for even healthy foods—usually resolve within 1–2 weeks. If nausea is severe, it can reduce food intake in ways that feel uncomfortable rather than beneficial. Working with a PlexusDx provider to optimize your dose ramp and manage side effects improves both tolerability and real-world weight loss.

How can the Precision Peptide Genetic Test help predict my first-month results?

The Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to GLP-1 therapy. Certain genetic profiles predict stronger appetite suppression and faster weight loss, while others may benefit from dual compounds like GLP-Squared Injection, allowing PlexusDx to personalize your treatment plan from day one.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Ozempic For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.